Journal of ethnopharmacology · 2025
Comprehensive lipid metabolites-pyroptosis profiling uncovers the therapeutic efficacy of Mailuo Shutong pill against Thromboangiitis obliterans.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
He Chenhan, Zhou Peipei, Zhang Zhibo, Yan Tongyin, Liu Liwei, Chu Yaojuan, Zuo Lihua, Zou Fanmei, Zhao Linguo, Wang Yifei, Du Shuzhang, Sun Zhi
Аннотация
ETHNOPHARMACOLOGICAL RELEVANCE: Thromboangiitis obliterans (TAO) is a necrotic lesion with complex inflammatory changes in the vessel wall. Mailuo Shutong pill (MLSTP), a traditional Chinese medicine formula (TCM) clinically prescribed for TAO, has been proven to possess good efficacy in treating TAO. However, the underlying mechanism of its action remains unclear.
AIM OF THE STUDY: To explore the mechanism of MLSTP in alleviating the sodium laurate-induced thromboobliteration using lipidomics and bioinformatics analysis.
METHODS: UHPLC-Q-Orbitrap-HRMS was used to identify compounds of MLSTP. Clinical score, pathological picture of gangrene, and hematoxylin-eosin staining were used to evaluate the antithrombin effect of MLSTP on the TAO model. Lipidomics was used to discover core biomarkers and lipid metabolism. The causal links between core biomarkers and compounds were forecast via bioinformatics analysis and verified through immunohistochemical stainings.
RESULTS: Eighty-five and fourteen prototype components were successfully identified in the plasma and right posterior femoral arteries, respectively. Pharmacodynamic studies suggested that MLSTP could exert noticeable vasoprotective effects on TAO rats. Moreover, twenty-three differential metabolites were found with sphingolipid metabolism, glycerolipid metabolism, linoleic acid metabolism, and alpha-linolenic acid metabolism. Besides, bioinformatics analysis predicted the pyroptosis genes associated with sphingolipid metabolism. Subsequently, the immunohistochemical analysis revealed that aberrant CerS1 overexpression in femoral arteries initiates sphingolipid metabolic dysregulation, which subsequently activates the CASP8/CASP3/GSDME-mediated pyroptosis pathway and drives overexpression of inflammatory cytokines (IL-1β, IL-18, TNF-α, IL-6). Integrating component identification, lipidomics, and bioinformatics analysis identified four lipid metabolism pathways and one pyroptosis pathway related to sphingolipid metabolism, which revealed multiple mechanisms of MLSTP against TAO involving remedying lipid disturbances and pyroptosis.
CONCLUSIONS: MLSTP alleviated sodium laurate-induced thromboobliteration by rectifying lipid homeostasis imbalance and inhibiting potential pyroptosis pathways. More importantly, it offered new perspectives on the mechanism of TAO.
AIM OF THE STUDY: To explore the mechanism of MLSTP in alleviating the sodium laurate-induced thromboobliteration using lipidomics and bioinformatics analysis.
METHODS: UHPLC-Q-Orbitrap-HRMS was used to identify compounds of MLSTP. Clinical score, pathological picture of gangrene, and hematoxylin-eosin staining were used to evaluate the antithrombin effect of MLSTP on the TAO model. Lipidomics was used to discover core biomarkers and lipid metabolism. The causal links between core biomarkers and compounds were forecast via bioinformatics analysis and verified through immunohistochemical stainings.
RESULTS: Eighty-five and fourteen prototype components were successfully identified in the plasma and right posterior femoral arteries, respectively. Pharmacodynamic studies suggested that MLSTP could exert noticeable vasoprotective effects on TAO rats. Moreover, twenty-three differential metabolites were found with sphingolipid metabolism, glycerolipid metabolism, linoleic acid metabolism, and alpha-linolenic acid metabolism. Besides, bioinformatics analysis predicted the pyroptosis genes associated with sphingolipid metabolism. Subsequently, the immunohistochemical analysis revealed that aberrant CerS1 overexpression in femoral arteries initiates sphingolipid metabolic dysregulation, which subsequently activates the CASP8/CASP3/GSDME-mediated pyroptosis pathway and drives overexpression of inflammatory cytokines (IL-1β, IL-18, TNF-α, IL-6). Integrating component identification, lipidomics, and bioinformatics analysis identified four lipid metabolism pathways and one pyroptosis pathway related to sphingolipid metabolism, which revealed multiple mechanisms of MLSTP against TAO involving remedying lipid disturbances and pyroptosis.
CONCLUSIONS: MLSTP alleviated sodium laurate-induced thromboobliteration by rectifying lipid homeostasis imbalance and inhibiting potential pyroptosis pathways. More importantly, it offered new perspectives on the mechanism of TAO.